This inventor holds 1 USPTO granted patent. Top assignees: Korea Basic Science Institute, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , University Of Louisville Research Foundation, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2023
Title: Christian Griesinger: Innovator in Platelet Count Enhancement
Introduction
Christian Griesinger is an accomplished inventor based in Louisville, KY (US). He has made significant contributions to the field of medicine, particularly in methods that enhance platelet counts in subjects. His innovative approach has the potential to impact various therapeutic applications.
Latest Patents
Griesinger holds a patent for a method of increasing platelet counts in a subject. This method involves administering a therapeutically effective amount of a compound that inhibits Biliverdin reductase B (BLVRB) activity. The compound works by blocking a binding site of BLVRB or utilizing a pharmaceutically acceptable salt, ensuring that it does not contain xanthene or acridine moieties. This patent represents a significant advancement in medical treatments related to platelet deficiencies.
Career Highlights
Throughout his career, Griesinger has worked with notable institutions, including the Korea Basic Science Institute and the University of Louisville Research Foundation, Inc. His work in these organizations has allowed him to further his research and develop innovative solutions in the medical field.
Collaborations
Griesinger has collaborated with esteemed colleagues, including Kyoung-Seok Ryu and Myeongkyu Kim. These partnerships have contributed to the advancement of his research and the development of his patented methods.
Conclusion
Christian Griesinger's contributions to the field of medicine through his innovative patent for increasing platelet counts highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile